It is well-known that in PD adaptive mechanisms, such as DAT downregulation, come into play to partially compensate for the loss of dopaminergic terminals and delay the clinical onset of motor signs in the early stage of the disease [30-32]. Here, SLC6A3 is linked to Parkinson disease.